EFECT OF ATORVASTATIN ON MCP-1 IN RATS WITH DIABETIC NEPHROPATHY
Zhao Wang
Abstract
Zhao Wang
Abstract
Objective:To explore the protective mechanism of Atorvastatin on kidneys indiabetic rats by investigating the effects of Atorvastatin on MCP-1 in rats with diabetic nephropathy.Methods:A total of 24 male SD rats induced by streptozocin were randomly divided into 3 groups,normol control,diabetes and dibetes treated by atorvastatin.24-hour urine protein were measured by automatic biochemistry analyzer and Expression of MCP-1 were detected by immunohistochemical staining.Results:24-hour urine protein in diabetic rats were significantly higher than those in normal rats (P0.01),Atorvastatin treatment significantly inhibited activation of MCP-1(P0.05),decreased urine protein excretion.Conclusion:Atorvastatin exerted protective effect on diabetic nephropathy,Which is probably one of the mechanisms that decreased the expression of MCP-1.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To explore the protective mechanism of Atorvastatin on kidneys indiabetic rats by investigating the effects of Atorvastatin on MCP-1 in rats with diabetic nephropathy.Methods:A total of 24 male SD rats induced by streptozocin were randomly divided into 3 groups,normol control,diabetes and dibetes treated by atorvastatin.24-hour urine protein were measured by automatic biochemistry analyzer and Expression of MCP-1 were detected by immunohistochemical staining.Results:24-hour urine protein in diabetic rats were significantly higher than those in normal rats (P0.01),Atorvastatin treatment significantly inhibited activation of MCP-1(P0.05),decreased urine protein excretion.Conclusion:Atorvastatin exerted protective effect on diabetic nephropathy,Which is probably one of the mechanisms that decreased the expression of MCP-1.
Key concepts: Atorvastatin, Diabetic nephropathy, Streptozocin, Urine, Medicine, Endocrinology, Immunohistochemistry, Nephropathy